|1.||Youngs, Wiley J: 5 articles (01/2012 - 01/2008)|
|2.||Panzner, Matthew J: 4 articles (01/2012 - 01/2008)|
|3.||Cannon, Carolyn L: 4 articles (01/2012 - 08/2009)|
|4.||Hindi, Khadijah M: 4 articles (09/2009 - 01/2008)|
|5.||Che, Chi-Ming: 3 articles (06/2014 - 06/2010)|
|6.||Yun, Yang H: 3 articles (01/2012 - 01/2008)|
|7.||Ditto, Andrew J: 3 articles (01/2012 - 01/2008)|
|8.||Brinker, Udo H: 2 articles (12/2015 - 04/2012)|
|9.||Ma, Dik-Lung: 2 articles (01/2015 - 06/2010)|
|10.||Leung, Chung-Hang: 2 articles (01/2015 - 06/2010)|
|1.||Respiratory Tract Infections (Respiratory Tract Infection)
08/01/2009 - "The development of a compound composed of silver coupled to a methylated caffeine carrier (silver carbene complex 1 [SCC1]) that demonstrated in vitro efficacy against bacteria, including drug-resistant organisms, isolated from patients with respiratory tract infections was described previously. "
04/01/2014 - "Metal-N-heterocyclic carbene complexes as anti-tumor agents."
01/01/2012 - "Advances in metal-carbene complexes as potent anti-cancer agents."
05/01/2015 - "Macrophage and colon tumor cells as targets for a binuclear silver(I) N-heterocyclic carbene complex, an anti-inflammatory and apoptosis mediator."
01/01/2015 - "BIAN N-Heterocyclic Gold Carbene Complexes induced cytotoxicity in human cancer cells via upregulating oxidative stress."
09/01/2014 - "Gold(I)-N-heterocyclic carbene complexes are of particular interest, because of their stability, ease of derivatization and clear cytotoxicity in cancer cells. "
|4.||Liver Neoplasms (Liver Cancer)
01/01/2015 - "The purpose of this study was to examine the cytotoxicity and possible mechanisms of action of two types of newly synthesized nanofiber composites containing BIAN N-heterocyclic gold carbene complexes in two types of human cancer cells, namely breast cancer (MCF7) and liver cancer (HepG2) cells and also in normal human embryonic kidney cells (HEK 293). "
|5.||Cystic Fibrosis (Mucoviscidosis)
|2.||Caffeine (No Doz)
|8.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|10.||2,2'-Dipyridyl (2,2 Bipyridine)